Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
Thanks to European approval of a new indication for Lucentis, preterm infants with ROP finally have a pharmacotherapeutic option
Drugs used to treat retinal disorders appear to pass into breast milk, posing a potential risk to the normal development of nursing infants
An OCT angiography image of a patient with proliferative diabetic retinopathy and severe ischemic changes
It is time for ophthalmology to embrace refractive surgery – for the sake of humankind
by EyePoint Pharmaceuticals
Michael Savetsky on the first — and only — FDA-approved intraocular steroid for postoperative inflammation
Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future
Eye-tracking technology presents promising biomarkers for identifying traumatic brain injury
AI image interpretation will not solve the diabetic retinopathy epidemic
Using tear osmolarity and MMP-9 as the basis of an ocular surface disease treatment algorithm
Enter the enhanced world of augmented reality…
Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency
NICE offers new option for retinal dystrophy patients
15-year study uncovers first known genetic cause for rare retinal disease
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.